- Active Substance: Growth Hormone-Releasing Peptide 2
- Concentration: 5 mg
- Pack Size: vial
- Manufacturer: Ultima Pharmaceuticals
- Brand Name: GHRP-2
SKU: P269
Shipping From
Understanding Ultima-GHRP-2 (Growth Hormone-Releasing Peptide 2) 5mg for Endocrine Research
Ultima-GHRP-2, offered by Ultima Pharmaceuticals, contains 5mg per vial of Growth Hormone-Releasing Peptide 2 (GHRP-2), also known as Pralmorelin. This synthetic peptide is being investigated in endocrine research for its potent ability to stimulate the release of growth hormone (GH) from the pituitary gland, as well as its potential effects on appetite and metabolism.
Mechanism of Action
GHRP-2 acts as a growth hormone secretagogue, binding to specific receptors (GHS-R1a) primarily located in the pituitary gland and hypothalamus. This binding stimulates the release of GH in a dose-dependent manner. Research also suggests GHRP-2 may influence the release of ghrelin, a hormone that stimulates appetite. The precise interplay between GHRP-2 and various metabolic pathways is an active area of endocrine research.
Benefits
- Investigated for its potent ability to stimulate growth hormone release.
- Studied for its potential effects on increasing appetite and influencing body weight regulation.
- Research into its role in modulating metabolic markers and energy expenditure.
- Exploration of its potential impact on muscle growth, recovery, and body composition (secondary to GH release).
- Studies on its potential applications in understanding and managing growth hormone deficiencies or metabolic disorders.
Please note: The potential benefits listed above are based on preclinical and some limited clinical research and have not been fully established in humans for widespread therapeutic use. GHRP-2 is a research compound and is not approved for human therapeutic use by regulatory authorities in many regions.
Usage Guidelines
As a research compound, any guidelines regarding its use are strictly within the context of laboratory and research settings. Administration protocols and dosages vary significantly depending on the specific research objectives and models. Common routes of administration in research include subcutaneous or intravenous injection. Dosing frequency and timing are often carefully controlled to study pulsatile GH release. Any information regarding human dosage or administration is speculative and not recommended.
Potential Side Effects
Research on GHRP-2 has reported potential side effects such as increased appetite, temporary water retention, and elevated prolactin and cortisol levels in some studies, particularly at higher doses. The long-term safety profile and the full range of potential side effects are still under investigation.
FAQ
What is Ultima-GHRP-2?
Ultima-GHRP-2 contains Growth Hormone-Releasing Peptide 2, a synthetic peptide being researched for its ability to stimulate growth hormone release.
How does GHRP-2 work in research to stimulate growth hormone?
Research shows it binds to specific receptors in the pituitary gland and hypothalamus, triggering the release of growth hormone.
What are the potential research benefits of GHRP-2?
Potential research benefits include potent growth hormone stimulation and potential effects on appetite and metabolism.
What are the potential side effects observed in research?
Research has reported potential increased appetite, temporary water retention, and elevated prolactin and cortisol levels in some studies.
Important Note: Ultima-GHRP-2 is a research compound and is not approved for human therapeutic use by regulatory authorities in many regions. Information provided here is strictly for research and informational purposes only. It is not intended as a guide for personal use. The use of such compounds carries potential risks, and their long-term effects are not fully understood. Consult with qualified healthcare professionals for any health concerns.